Misonix has entered into new, multi-year agency agreements with six leading regional spine surgery sales organizations for the marketing of the Misonix BoneScalpel Ultrasonic Bone Cutting System. The agreements are indicative of the company's commitment to capitalize on the growing clinical use of the BoneScalpel in advanced spine surgery procedures. Each agreement is performance based with each agency committing to certain levels of sales. Product training has been completed and open market sales have commenced.
As traders wait on the Federal Reserve, putting off any major decisions until they hear the latest word in FOMC …